Apollomics, Inc.
Apollomics, Inc. scores highest on Nitro (57) and lowest on Price (0). Its PosiPenta is 39.48 out of 100, weaker than most similar companies.
On the Penta Grid this week, Apollomics, Inc. is Grid #561 of 836 in the Healthcare sector in United States, and Grid #2,941 of 3,999 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Apollomics, Inc. | 39.48 | 0 | 43 | 57 | 48 | 50 |
| electroCore, Inc. | 53.77 | 0 | 51 | 64 | 99 | 55 |
| Microbot Medical Inc. | 40.90 | 41 | 43 | 23 | 66 | 32 |
| Fortress Biotech, Inc. | 57.23 | 93 | 46 | 27 | 69 | 50 |
| Spero Therapeutics, Inc. | 51.82 | 75 | 39 | 24 | 74 | 47 |
| Pelthos Therapeutics Inc. | 29.18 | 0 | 37 | 45 | 20 | 44 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -2.79 |
| P/B ratio | -19.29 |
EEarnings
| Trailing EPS | ₹-716.99 |
| Forward EPS | ₹-61.56 |
NNitro
| Price | 1998.49 |
| 52-week high | 3790.02 |
| 52-week low | 947.72 |
| Fall from 52-week high | 47.3% |
TTorque
| Return on equity (ROE) | -1305.37% |
| Debt-to-equity | -0.20 |
AAnchor
| Beta (price swings) | 1.54 |
| Market cap | ₹582 Cr |
| Insider holding | 56.46% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Apollomics, Inc.'s PosiPenta score?
Apollomics, Inc.'s PosiPenta is 39.48 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Apollomics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Apollomics, Inc. is Grid #561 of 836 in the Healthcare sector in United States, and Grid #2,941 of 3,999 in United States.
Which PosiPenta pillar is strongest for Apollomics, Inc.?
Nitro (momentum), with a score of 57 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Apollomics, Inc.?
Price (valuation), with a score of 0 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.